Thursday, July 26, 2018
Wednesday, July 25, 2018
Tuesday, July 24, 2018
Wednesday, July 18, 2018
Tuesday, July 17, 2018
Allergan: Crucial Period Ahead For Company As Activist Pressure Mounts
Allergan is under pressure from activist shareholders and other investors to formulate a clear strategic plan and make more drastic changes to the company.
Botox Aesthetics, Botox Migraine, and Restasis will all face upcoming competition which could hamper sales growth.
Critical catalysts are approaching that could materially change whether the company makes more drastic changes or not. Expect important readouts from ubrogepant, abicipar, and rapastinel over the next 6-9 months.
Monday, July 16, 2018
Friday, July 13, 2018
Wednesday, July 11, 2018
Monday, July 9, 2018
Friday, July 6, 2018
Thursday, July 5, 2018
Subscribe to:
Posts (Atom)